Buck Kristen K has filed 24 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 13000 shares of LISATA THERAPEUTICS, INC. ($LSTA) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 8,820,733 | 9999.99% | 0.15% |
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2147 | $1.97 | 93,462.0000 | 8,820,733 | 2.25% | 0.02% |
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 3221 | $1.97 | 95,609.0000 | 8,820,733 | 3.26% | 0.04% |
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2982 | $1.97 | 98,830.0000 | 8,820,733 | 2.93% | 0.03% |
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2982 | $1.97 | 101,812.0000 | 8,820,733 | 2.85% | 0.03% |
| Jan. 9, 2026 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Common Stock | 25000 | $0.00 | 104,794.0000 | 8,820,733 | 31.33% | 0.28% |
| Jan. 9, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Common Stock | 25000 | $0.00 | 87,672.0000 | 0 | 39.89% | 0.00% |
| Jan. 9, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2651 | $3.80 | 85,021.0000 | 0 | 3.02% | 0.00% |
| Jan. 9, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2863 | $3.80 | 82,158.0000 | 0 | 3.37% | 0.00% |
| Jan. 9, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 1908 | $3.80 | 80,250.0000 | 0 | 2.32% | 0.00% |
| Jan. 10, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 456 | $3.73 | 79,794.0000 | 0 | 0.57% | 0.00% |
| Jan. 9, 2025 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 6363 | $2.93 | 62,672.0000 | 0 | 9.22% | 0.00% |
| Oct. 1, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Common Stock | 15000 | $2.93 | 69,035.0000 | 0 | 27.76% | 0.00% |
| Jan. 10, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 512 | $3.00 | 54,035.0000 | 0 | 0.94% | 0.00% |
| Jan. 9, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Stock Option (Right to Buy) | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2147 | $3.08 | 54,547.0000 | 0 | 3.79% | 0.00% |
| Jan. 9, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 3221 | $3.08 | 56,694.0000 | 0 | 5.38% | 0.00% |
| Jan. 9, 2024 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Common Stock | 27000 | $0.00 | 59,915.0000 | 0 | 82.03% | 0.00% |
| Sept. 1, 2023 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2908 | $2.18 | 32,915.0000 | 0 | 8.12% | 0.00% |
| Jan. 9, 2023 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 2147 | $3.00 | 36,335.0000 | 0 | 5.58% | 0.00% |
| Jan. 10, 2023 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | F | Common Stock | 512 | $3.20 | 35,823.0000 | 0 | 1.41% | 0.00% |
| Jan. 9, 2023 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Stock Options (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | LISATA THERAPEUTICS, INC. | $LSTA | Buck Kristen K | EVP, R&D and CMO | A | Common Stock | 18000 | $0.00 | 38,482.0000 | 0 | 87.88% | 0.00% |